Back to 
CAPSTONE INVESTMENT ADVISORS, LLC
CAPSTONE INVESTMENT ADVISORS, LLC
ATOS
Showing 0 of 2 quarters
Position history for CAPSTONE INVESTMENT ADVISORS, LLC's holdings in ATOSSA THERAPEUTICS INC
No. Capstone Investment Advisors exited its ATOS (Atossa Therapeutics) position in Q2 2021. Its Q1 2021 13F listed 51,257 shares worth $108,000. Capstone Investment Advisors first reported ATOS in Q1 2021 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.